Clinical Trial: Construction and Evaluation of an Intelligent Decision System for Reperfusion Therapy in Acute Ischemic Stroke

U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07316049) titled 'Construction and Evaluation of an Intelligent Decision System for Reperfusion Therapy in Acute Ischemic Stroke' on Dec. 02, 2025.

Brief Summary: This multicenter, cluster-randomized controlled trial will evaluate the effectiveness and safety of the LingBao System, an AI-enabled clinical decision support platform for reperfusion therapy in acute ischemic stroke (AIS). Twenty certified stroke centers will be randomized 1:1 to LingBao-assisted care or standard care. Consecutive patients aged 18 years or older who present within 24 hours of symptom onset or last-known-well and are evaluated for intravenous thrombolysis and/or endovascula...